The economic impact of asthma on private healthcare system in Brazil: Economic impact of asthma in Brazil.

Autor:	Nascimento OA; GlaxoSmithKline, Rio DE Janeiro, Brazil.; Disciplina de Pneumologia, Escola Paulista de Medicina, Universidade Federal de São Paulo - EPM/UNIFESP, São Paulo (SP), Brasil.; Faculdade de Medicina São Leopoldo Mandic, Campinas (SP), Brasil., Cançado JED; Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil., Gazzotti MR; GlaxoSmithKline, Rio DE Janeiro, Brazil.; Disciplina de Pneumologia, Escola Paulista de Medicina, Universidade Federal de São Paulo - EPM/UNIFESP, São Paulo (SP), Brasil., Dos Santos FM; GlaxoSmithKline, Rio DE Janeiro, Brazil., Saturnino LTM; GlaxoSmithKline, Rio DE Janeiro, Brazil., da Silva DO; GlaxoSmithKline, Rio DE Janeiro, Brazil., Gomes ALBB; Orizon, São Paulo, Brazil., Viana KP; GlaxoSmithKline, Rio DE Janeiro, Brazil., Alfonso-Cristancho R; GlaxoSmithKline, Collegeville, PA., Rodrigues CS; GlaxoSmithKline, Rio DE Janeiro, Brazil.
Jazyk:	angličtina
Zdroj:	Medicine [Medicine (Baltimore)] 2023 Mar 24; Vol. 102 (12), pp. e33077.
DOI:	10.1097/MD.0000000000033077
Abstrakt:	To assess healthcare resource utilization and costs of patients with asthma in Brazilian Supplementary Healthcare System, focusing on hospitalization data. Retrospective cohort study, using data from an administrative database of a private company (Orizon). Patients aged ≥ 12 years with at least one record of emergency visit/hospitalization in the database with the ICD-10 J45 between January/2010 and June/2015 were included and followed until June/2016, death or inactivation of health plan. Sociodemographic characteristics, emergency visit and hospital admission per patient per year (exacerbation rate), physician visit with a procedure, exams, length of hospitalization (with/without intensive care unit (ICU)), and in-hospital treatments were assessed. A total of 54,568 patients were included in this analysis. Regarding resource utilization, emergency visit and hospital admission rates of 0.34 and 0.04 per person-year were observed, respectively. Mean length of hospital stay were 8.82 (SD = 36.48), 5.24 (SD = 19.06) and 19.53 (63.89) days for hospitalizations in general, without and with ICU, respectively. An exacerbation rate of 0.36 per person year was observed with a mean cost per episode of 3178 Brazilian Real (BRL) (SD = 31,667). Mean cost related to emergency department visits was estimated at 293 BRL (SD = 328). Hospitalization costs were stratified by the need of ICU and values observed were of 9307 BRL (SD = 18,979) without ICU, and 75,252 BRL (SD = 174,248) with ICU need. Asthma exacerbations may cost ~75,000 BRL for an ICU-dependent event in the Supplementary Healthcare System. To improve disease control may reduce disease burden for both healthcare system and patients. Competing Interests: JEDC and ALBBG have no conflicts of interest to disclose. (Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu